Stocks and InvestingStocks and Investing
Thu, November 30, 2023
Wed, November 29, 2023
Tue, November 28, 2023
Mon, November 27, 2023

Arthur He Reiterated (CALT) at Strong Buy and Held Target at $50 on, Nov 27th, 2023


Published on 2024-10-28 07:44:44 - WOPRAI, Arthur He
  Print publication without navigation


Arthur He of HC Wainwright & Co., Reiterated "Calliditas Therapeutics AB (publ)" (CALT) at Strong Buy and Held Target at $50 on, Nov 27th, 2023.

Arthur has made no other calls on CALT in the last 4 months.



There are 2 other peers that have a rating on CALT. Out of the 2 peers that are also analyzing CALT, 1 agrees with Arthur's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Vamil Divan of "Guggenheim" Maintained at Hold with Decreased Target to $18 on, Friday, August 18th, 2023


This is the rating of the analyst that currently disagrees with Arthur


  • Edwin Zhang of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $50 on, Monday, October 16th, 2023